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Association Between Pain, Radiographic Severity,
and Centrally-Mediated Symptoms in Women
With Knee Osteoarthritis
SUSAN L. MURPHY,1 ANGELA K. LYDEN,2 KRISTINE PHILLIPS,2 DANIEL J. CLAUW,2 AND
DAVID A. WILLIAMS2
Objective. To examine the relationship between pain, radiographic severity, and a common set of co-occurring centrally-
mediated symptoms (fatigue, sleep quality, and depression) in women with knee osteoarthritis.
Methods. Participants underwent knee radiographs, and had repeated assessments of pain severity and other centrally-
mediated symptoms during a 5-day home monitoring period. To examine associations between pain severity (the average
of pain over the home monitoring period), measures of osteoarthritis radiographic severity (Kellgren/Lawrence grade,
minimum joint space width), centrally-mediated symptoms, and demographics (age) were used. Symptoms of fatigue,
sleep efﬁciency, and depression were used in a composite measure representing centrally-mediated symptoms.
Results. Using a series of linear regression models in which each variable was entered hierarchically (n  54), the ﬁnal
model showed that 27% of the variance in pain severity was explained by age, radiographic severity, and centrally-
mediated symptoms. Centrally-mediated symptoms explained an additional 10% of the variance in pain severity after the
other 2 variables were entered.
Conclusion. Both radiographic severity and centrally-mediated symptoms were independently and signiﬁcantly associ-
ated with pain severity in women with knee osteoarthritis. In addition to more severe radiographic features, women with
higher centrally-mediated symptoms had greater pain severity. Treatments for women with symptomatic knee osteoar-
thritis may be optimized by addressing both peripheral and central sources of pain.
INTRODUCTION
Osteoarthritis is a leading cause of disability among older
adults (1) and is often characterized by pain, the most
common symptom for which people with osteoarthritis
seek treatment. Pain in osteoarthritis affects the ability to
engage in activities of daily living, work, and other mean-
ingful activities, and is associated with a reduced quality
of life (2–4). Knee pain due to osteoarthritis in particular is
a main cause of impaired mobility among older adults (5).
Women with arthritis have more functional deﬁcits than
men, reporting more severe joint pain, more psychological
distress, and greater limitations on activity (6).
Despite the negative impact of osteoarthritis pain, its
underlying causes are not well understood. Pain in osteo-
arthritis has been hypothesized to be complex and caused
by both peripheral and central sources (7–9). Although
treatment for knee osteoarthritis is typically targeted at
peripheral sources (i.e., alleviating joint pain), population-
based studies have shown that radiographic severity of
knee osteoarthritis and pain are only weakly associated
(10,11). In some studies, however, this relationship was
found to be stronger, for instance, when methods were
used that controlled for between-person effects (using a
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within-person matched knee design) (12), and when the
more functionally-based Western Ontario and McMaster
Universities Osteoarthritis Index (WOMAC) pain scale
was used (13). Nevertheless, the association between ra-
diographic severity in osteoarthritis and pain remains im-
perfect and requires further examination. There are still
many individuals who have radiographic evidence of os-
teoarthritis in the absence of pain (11,14) and there are
those who have little radiographic evidence of osteoarthri-
tis with moderate to severe pain.
There is growing evidence that central nervous system
factors may be playing a prominent role in maintaining
osteoarthritis pain in certain individuals. In animal stud-
ies, central sensitization in osteoarthritis has been noted
by altered spinal nociceptive processing (15,16). In clini-
cal studies, compared to controls, participants with knee
osteoarthritis had more diffuse hyperalgesia to mechanical
or heat stimuli (17,18). Furthermore, pharmacologic stud-
ies have demonstrated that compounds that alter pain
neurotransmitters centrally such as serotonin and norepi-
nephrine (e.g., duloxetine, tricyclics) are efﬁcacious in
knee osteoarthritis (19,20).
Central involvement in pain is often accompanied by
non–region-speciﬁc symptoms that are systemically medi-
ated, such as fatigue, cognitive problems, sleep problems,
and perturbations of mood (21–23). In fact, in a recent
cluster analysis of older adults with symptomatic knee or
hip osteoarthritis, one-third of the sample had a high level
of these types of “centrally-mediated” symptoms (24).
Many of these symptoms are associated with increased
pain severity in osteoarthritis. For instance, pain in osteo-
arthritis is a predictor of sleep disturbance (25), was found
to mediate a large amount of the relationship between
arthritis and sleep problems (26), and was most associated
with having any sleep problem in combination with hav-
ing radiographic evidence of osteoarthritis (27). Pain is
also associated with higher levels of depression in several
studies (25,26,28–34) and with fatigue (35,36). In 1 study,
fatigue was the strongest predictor of pain on the WOMAC
scale (36), and fatigue is also correlated with both sleep
disturbance and depression (33,35,37).
Although many of these centrally-mediated symptoms
are interrelated and associated with increased pain sever-
ity, no studies to our knowledge have examined these
symptoms in aggregate along with their combined contri-
bution to pain severity in osteoarthritis above and beyond
peripheral factors. The purpose of this study was to exam-
ine the associations of central and peripheral factors with
osteoarthritis pain. We hypothesized that central factors
(represented by centrally-mediated symptoms other than
pain) would explain additional variance in pain severity,
after controlling for demographics (age) and radiographic
severity.
PATIENTS AND METHODS
Participants. For this analysis, participants came from 2
samples. In sample 1, participants consisted of women
between the ages of 55 and 80 years who were involved in
a cross-sectional study that examined the relationship be-
tween pain, fatigue, and physical activity (38). Participants
were recruited through ﬂiers, a research participant regis-
try maintained by the University of Michigan’s Claude D.
Pepper Center, and a clinical studies web site at the Uni-
versity of Michigan. There were 65 people in the original
sample. Five participants had data collected only to pilot
our procedures but had complete data and were therefore
included in this analysis, and the remaining 60 (40 with
knee or hip osteoarthritis and 20 age-matched controls)
have been described previously (38). In this analysis, we
included only participants who had symptomatic knee
osteoarthritis that was deﬁned as radiographic evidence of
osteoarthritis (Kellgren/Lawrence score 2) and at least
mild reported pain on the WOMAC pain scale. They also
needed to report having knee pain for at least 3 months in
duration. The resulting sample size was 41. Sample 2 had
42 participants ages 50 years and older who were random-
ized into 1 of 2 intervention arms of a pilot randomized
controlled trial and who completed a baseline assessment
involving assessment of pain and other symptoms and
physical function (39). Participants were recruited through
ﬂiers and advertisements in senior center newsletters. Par-
ticipants were eligible for the study if they had deﬁnitive
radiographic evidence of knee or hip osteoarthritis (Kell-
gren/Lawrence score 2), had joint pain for at least 3
months in duration, and reported mild to moderate joint
pain on the WOMAC pain scale. From these 42, we ex-
cluded people with hip osteoarthritis or who were men,
and 3 people whose home monitoring data were deemed
unusable, leaving 14 people in sample 2. The combined
sample in this study was 55.
Individuals in both samples were excluded from partic-
ipating if they were nonambulatory, had medical condi-
tions other than osteoarthritis that interfered with activity
performance or caused pain and fatigue, had a joint re-
placement or surgery of the knee or hip in the previous 6
months, had inadequate cognition (by Mini-Mental State
Examination or 6-Item Screener), or could not operate the
wrist-worn accelerometer used in the study protocols. Par-
ticipants in the pilot randomized controlled trial (sample
2) also were excluded if they were undergoing current
nonpharmacologic treatment for osteoarthritis (e.g., reha-
bilitation, injections).
Measures. Radiographic assessment. Semiﬂexed bilat-
eral standing radiographs were taken of the knees in an
Signiﬁcance & Innovations
● A cluster of centrally-mediated symptoms (repre-
senting the manifestation of central pain) ex-
plained a small but signiﬁcant amount of variance
in pain severity, even after age and radiographic
severity were taken into account.
● The co-occurrence of pain severity with centrally-
mediated symptoms supports the idea that osteo-
arthritis treatment needs to be broadened to im-
pact all potentially modiﬁable factors.
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anteroposterior view. Radiographs were graded using the
Kellgren/Lawrence scale (range 0–4) in each study by a
radiologist, and measurement of minimum joint space
width (MJSW) was done by a rheumatologist on our study
team (KP). Both had expertise in reading radiographs and
were blinded to the participants’ symptom levels.
Pain. Pain was assessed in 2 ways in each study. Pain
was assessed repeatedly over a 5-day home monitoring
period in which participants rated their pain severity 6
times per day. They input responses into a wrist-worn
accelerometer (Actiwatch-Score; Philips Respironics-Mini
Mitter) that also concurrently measured physical activity
levels. Pain was assessed on a scale of 0–4 by sample 1
and on a scale of 0–10 by sample 2. Because of the differ-
ent scaling, a Z score was calculated for each participant in
order to compare pain severity across studies. The ratings
were averaged over the 5 days to generate an average pain
severity score for each participant. Pain was also assessed
using the WOMAC scale administered to participants with
osteoarthritis at the baseline visit. Because of our interest
in multifocal pain mechanisms, we chose to use the as-
sessment of pain severity as the outcome in this analysis
rather than the WOMAC pain scale, as we think it better
captures global pain experience compared to a disease-
speciﬁc, more functionally-based instrument.
Centrally-mediated symptoms. Non–region-speciﬁc
symptoms accompanying pain such as fatigue, cognitive
problems, sleep problems, and perturbations of mood are
systemically-mediated symptoms that may index more
central nervous system involvement in the maintenance of
illnesses, such as pain (21–23). Therefore, we chose all
available symptom measures that may indicate the pres-
ence of central involvement, i.e., fatigue, sleep efﬁciency,
and depressive symptoms. Fatigue was measured similar
to pain severity, in which participants in samples 1 and 2
rated fatigue severity 6 times per day over 5 days on scales
of 0–4 and 0–10, respectively. To accommodate for the
scale differences, fatigue severity ratings were averaged
and Z scored per participant. Sleep efﬁciency was mea-
sured using the Actiwatch-Score that measures daytime
and nighttime activity fromwhich sleep and wake patterns
can be derived. The data were collected over a series of
24-hour days via a small wrist-worn accelerometer. This
method is widely used and validated (40,41), and there is
strong concordance between accelerometry and polysom-
nography on parameters such as total sleep time, wake
after sleep onset, number of awakenings, and sleep efﬁ-
ciency (42). Although polysomnography is the accepted
measure of sleep architecture, accelerometry may better
tap sleep-related behaviors and routines because it can
occur in the home and is less obtrusive (40,43). For this
analysis, we used sleep efﬁciency, which indicates the
percentage of time spent asleep relative to the time spent
in bed. Depressive symptoms were measured in both stud-
ies using the Geriatric Depression Scale (44). Measures of
fatigue, sleep efﬁciency, and depressive symptoms were
formed into a composite for analysis by Z scoring the
measures and summing them for each participant.
Statistical analysis. We ﬁrst examined the bivariate cor-
relations among all of the variables to examine the inter-
relationships. Then we performed a hierarchical series of
linear regressions to determine how each variable contrib-
uted to pain severity. We examined contributions of age,
radiographic features of osteoarthritis (MJSW, Kellgren/
Lawrence grade), and centrally-mediated symptoms. Miss-
ing values were replaced with the group mean for that
variable. For the radiographic features of osteoarthritis, we
used the values from each participant’s designated joint,
i.e., the joint chosen by the participant as having the most
pain.
RESULTS
The baseline characteristics of the sample are shown in
Table 1. The 2 samples were similar with respect to age
Table 1. Baseline characteristics of the sample (n  55)*
Variable
Total
sample
Sample 1
(n  41)
Sample 2
(n  14)
Age, mean  SD years 62.63  7.50 62.83  7.39 61.29  7.64
White, no. (%) 43 (78.2) 34 (82.9) 9 (64.3)
Married, no. (%) 27 (49.0) 22 (53.7) 5 (35.7)
BMI, mean  SD kg/m2 31.12  5.67 31.14  5.68 31.89  6.42
Kellgren/Lawrence grade (n  53)
1 4 4 0
2 27 22 6
3 16 12 4
4 6 2 4
MJSW, mean  SD 3.03  1.85 3.34  1.85† 2.11  1.52
Average weekly pain, mean  SD‡ 0.95  0.79† 3.42  1.57
Average weekly fatigue, mean  SD‡ 1.02  0.74† 3.28  1.57
Geriatric Depression Scale (n  53), mean  SD 1.89  2.20 2.00  2.33 1.50  1.70
Sleep efﬁciency, mean  SD % 88.00  5.09 88.41  5.31 85.87  5.09
* BMI  body mass index; MJSW  minimum joint space width.
† Signiﬁcantly different from sample 2 at P  0.05.
‡ Average weekly pain and fatigue were rated on a scale of 0–4 for sample 1 and on a scale of 0–10 in sample 2, and these values are shown above.
The independent t-tests between samples for pain and fatigue were performed using the Z-scored variables.
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and body mass index, and sample 2 had a greater propor-
tion of African American participants compared to sample
1. There were differences in radiographic severity between
the 2 samples in that sample 2 presented signiﬁcantly
greater joint space narrowing (P  0.03); however, the
percentages of individuals with Kellgren/Lawrence grades
of 3 or 4 versus grades 1 or 2 were similar between the 2
samples (2  2.85, Fisher’s exact test P  0.11). Sample 2
was also more symptomatic than sample 1, presenting
with greater levels of both pain and fatigue. Samples 1 and
2 did not differ signiﬁcantly on sleep efﬁciency, and their
levels were relatively high (88% and 86%, respectively).
Correlations were examined to determine how pain se-
verity related to age, radiographic severity, and centrally-
mediated symptoms (Table 2). Variables representing ra-
diographic severity and centrally-mediated symptoms had
small to moderate associations with pain severity. Of the
predictor variables, small to moderate relationships were
found between centrally-mediated symptoms and Kell-
gren/Lawrence grade (r  0.29) and between Kellgren/
Lawrence grade and MJSW (r  0.36).
In performing the linear regressions, predictors were
entered in separate steps in a hierarchical manner: 1) age,
2) radiographic severity variables of Kellgren/Lawrence
grade and MJSW, and 3) centrally-mediated symptoms.
The steps were chosen in this order because it was of
particular interest to determine the added contribution of
centrally-mediated symptoms to pain severity in a model
with factors that physicians may more commonly consider
when treating osteoarthritis pain (i.e., demographics and
osteoarthritis disease severity). We ﬁrst evaluated the
model diagnostics. The residuals were normally distrib-
uted, although an analysis of the Cook’s D conﬁrmed that
1 participant had the potential for undue inﬂuence on the
overall model. This particular participant had an average
pain rating that was 4 SDs from the sample mean. We
removed this participant from the data set and reran the
analysis (n  54). Although the betas in both series of
regressions with and without this participant were similar,
the series without the participant was the best-ﬁtting
model and is summarized in Table 3. Radiographic sever-
ity variables and centrally-mediated symptoms added a
signiﬁcant proportion of variance in pain severity. Con-
trolling for age, radiographic severity explained 17%
(F[2,50]  5.10, P  0.01) of the variance in pain severity.
Including centrally-mediated symptoms in the model
added another 10% of the variance (F[1,49]  6.51, P 
0.01). Overall, more than one-quarter of the variance (R2 
0.27) in pain severity was predicted by the 4 independent
variables. In these models, increasing radiographic sever-
ity (increasing Kellgren/Lawrence grade or decreasing
joint space width) was associated with greater pain sever-
ity; however, centrally-mediated symptoms were most
strongly independently associated with pain severity
(standardized   0.33, 95% conﬁdence interval 0.04–
0.34).
DISCUSSION
This study found that in a group of community-dwelling
adults ages 50 years, both radiographic severity and cen-
trally-mediated factors contributed to pain severity. In
support of our hypothesis, centrally-mediated symptoms
explained additional variance in pain severity beyond age
and radiographic severity. This was a small but signiﬁcant
addition to the model.
The association between pain severity and radiographic
features of osteoarthritis in population-based samples is
typically weak (10,11), although it is stronger in a study
controlling for between-person differences (12). In our
study, radiographic severity was independently associated
with pain severity and contributed 17% of variance to the
model. This relatively strong relationship between radio-
graphic severity and pain may be due in part to how
sample 1 was selected, in that people with radiographic
osteoarthritis needed to have at least minimal pain (5 on
the WOMAC pain scale). We also used 2 parameters of
Table 2. Correlations between pain severity and factors
included in regression models*
K/L
grade MJSW
Centrally-
mediated
symptoms
Pain
severity
Age 0.14 0.15 0.07 0.01
K/L grade 0.36† 0.29‡ 0.32‡
MJSW 0.10 0.35‡
Centrally-mediated
symptoms
0.39†
* K/L  Kellgren/Lawrence; MJSW  minimum joint space width.
† P  0.01.
‡ P  0.05.
Table 3. Factors associated with pain severity in women with knee osteoarthritis (n  54)*
Measure Total R2
F ratio
for R2
Cumulative
R2 by step
F ratio
by step
Unstandardized

Standardized
 P
Average pain severity 0.27 4.46†
Age 0.000 0.01 0.01 0.10 0.44
Osteoarthritis severity 0.17 5.10†
K/L grade 0.15 0.14 0.32
MJSW 0.13† 0.28 0.05
Centrally-mediated symptoms 0.10 6.51‡ 0.19‡ 0.33 0.01
* df 4,49. K/L  Kellgren/Lawrence; MJSW  minimum joint space width.
† P  0.05.
‡ P  0.01.
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radiographic severity, both the Kellgren/Lawrence score
and MJSW narrowing, which may have increased our abil-
ity to explain variance in the model. Other markers of
osteoarthritis severity from radiographs, such as number of
osteophytes, have been inconsistently associated with
knee pain (32,36). However, in studies using magnetic
resonance imaging of the knee joint, factors that have been
associated with knee pain severity include ﬂattening of
articular surfaces and bone marrow lesions (45) as well as
subchondral bone plate exposure (46). To more fully un-
derstand the peripheral contribution of pain in knee os-
teoarthritis, it appears important to consider these types of
factors.
The ﬁndings from this study show that additional vari-
ance in the model was explained by a cluster of centrally-
mediated symptoms. Separately, each of these symptoms
has been associated with pain severity and there are strong
associations between pain severity and sleep disturbance
(25–27) and depression (25,26,28–34). Kim et al (34) found
that the relationship between depression and pain severity
was stronger for people with less radiographic severity
(Kellgren/Lawrence grade of 0 or 1) compared to those
with greater levels of radiographic severity, suggesting that
depression may be one explanatory factor for discrepan-
cies in the relationship between pain and radiographic
severity. We examined whether one symptom, such as
depression, was driving the effect of centrally-mediated
symptoms in the model. However, this does not appear to
be the case as the frequency of the most severe symptom
reported (as denoted by the largest absolute value of each
Z score in the composite) was somewhat evenly distrib-
uted: 37% had the most severe depression in the compos-
ite, 37% had the most severe sleep disturbance, and 26%
had the most severe fatigue.
The main limitation of this study was the highly select
sample that had symptomatic knee osteoarthritis and did
not report other medical conditions known to cause pain
and fatigue that may be centrally mediated (such as ﬁbro-
myalgia and low back pain). Exclusion of people without
these comorbid conditions could have led to an underes-
timation of the association between centrally-mediated
symptoms and pain severity. Replication is needed to de-
termine whether the estimates found in the model are
reliable. In addition, generalizability of the study ﬁndings
are limited to women and it is not clear if these ﬁndings
would be replicated in male samples, as men tend to report
lower levels of symptoms (6). The cross-sectional design of
this study limits the ability to examine causality. However,
the centrally-mediated symptoms in aggregate help to ex-
plain the variance in pain beyond demographic or disease
severity factors. While the small sample size limited the
ability to build a model with many predictors, other de-
mographic factors may also be important to include, such
as body mass index, as it has been associated with a
measure of pain severity in an adjusted model (32). It
should be noted that pain severity (averaged over a 5-day
period) was measured differently in this study than in
most other studies. However, compared to recall-based
measures, this measure of pain severity is considered to be
more ecologically valid and does not have the weakness of
being biased by peak or recent experiences (47). Lastly,
although this study provides support for the contribution
of centrally-mediated symptoms as a symptom cluster in-
ﬂuencing pain severity, we did not have data from quan-
titative sensory testing to examine pain threshold or sen-
sitivity in these participants. These latter measures would
provide an index of patients’ inherent sensitivity to pain-
ful stimuli in addition to the amount of clinical pain they
were experiencing.
Despite limitations, this study is the ﬁrst to our knowl-
edge that examined the unique contributions of peripheral
and central factors on pain severity in women with knee
osteoarthritis. It also adds to a knowledge base on the
heterogeneity in knee osteoarthritis pain (7,48). Given this
heterogeneity, there are some potential clinical implica-
tions of this study. The majority of osteoarthritis pharma-
cologic and rehabilitation treatments are geared toward
alleviating pain due to disease severity in the joint; there-
fore, it appears important to optimize treatment for people
who have pain beyond peripheral sources. Because
women with higher pain severity in this study also had a
greater presence of centrally-mediated symptoms, high re-
ported pain severity may be one way to identify patients
who should be further screened for the presence of depres-
sion, fatigue, and sleep disturbance. Furthermore, the co-
occurrence of pain with these other symptoms provides
support for the development of multifaceted interventions
that could impact these potentially modiﬁable symptoms.
In 1 study, Lin et al found that an intervention to reduce
depression also reduced arthritis pain interference in peo-
ple with osteoarthritis, providing support for these types
of interventions (49). In addition, we found that fatigue
inference was signiﬁcantly improved by an occupational
therapist–led activity pacing intervention in a pilot study
of people with symptomatic knee and hip osteoarthritis
(39).
Future studies should be done to examine the underly-
ing pain mechanisms in people who present with central-
ly-mediated symptoms in knee osteoarthritis. While we
have used a proxy measure for central sensitization in this
study, more sophisticated aggregated indices of central
mechanisms are needed to examine the relationship be-
tween this clinical symptom presentation and pain sever-
ity. One way to better understand the role of central sen-
sitization in osteoarthritis pain is to examine the response
to treatments that target central pain processing. In addi-
tion to the studies of pharmacologic treatments, such as
duloxetine (19,20), nonpharmacologic approaches should
also be examined for their effect on central sensitization
and centrally-mediated pain. Several rehabilitative strate-
gies, such as manual therapy, behavioral therapy, and
transcutaneous electrical nerve stimulation, should be ex-
amined as potential ways to target central sensitization
(50).
Due to the growing evidence of osteoarthritis as a mixed
peripheral/central pain state, we examined associations
between pain severity and variables representing periph-
eral and central factors that could contribute to osteoar-
thritis pain. We found signiﬁcant independent associa-
tions between pain severity, radiographic severity, and
centrally-mediated symptoms. Centrally-mediated symp-
toms added signiﬁcant additional variance in the model
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after controlling for age and radiographic features and
may need to be addressed in osteoarthritis management
strategies.
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